| 1 |
Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter 2011;16:382-388.
DOI
|
| 2 |
Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev 2014;13:459-462.
DOI
|
| 3 |
Lee OJ, Lee EJ, Kim HJ. Correlations among gastric juice pH and ammonia, Helicobacter pylori infection and gastric mucosal histology. Korean J Intern Med 2004;19:205-212.
DOI
|
| 4 |
Kitamura Y, Yoshihara M, Ito M, et al. Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels. J Gastroenterol Hepatol 2015;30:1473-1477.
DOI
|
| 5 |
Di Mario F, Cavallaro LG, Moussa AM, et al. Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci 2006;51:1791-1795.
DOI
|
| 6 |
Kitamura S, Yasuda M, Muguruma N, et al. Prevalence and characteristics of nodular gastritis in Japanese elderly. J Gastroenterol Hepatol 2013;28:1154-1160.
DOI
|
| 7 |
Yoshida T, Kato J, Inoue I, et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer 2014;134:1445-1457.
DOI
|
| 8 |
Choi HS, Lee SY, Kim JH, et al. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm. J Dig Dis 2014;15:293-298.
DOI
|
| 9 |
Bornschein J, Selgrad M, Wex T, Kuester D, Malfertheiner P. Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol 2012;12:10.
DOI
|
| 10 |
Lee SY. Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised? J Gastroenterol Hepatol 2012;27:200-211.
DOI
|
| 11 |
Yanaoka K, Oka M, Mukoubayashi C, et al. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev 2008;17:838-845.
DOI
|
| 12 |
Yoo JY, Kim N, Park YS, et al. Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. J Clin Gastroenterol 2007;41:751-755.
DOI
|
| 13 |
Kim CG, Choi IJ, Lee JY, et al. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer. J Gastroenterol Hepatol 2009;24:469-474.
DOI
|
| 14 |
Masuyama H, Yoshitake N, Sasai T, et al. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion 2015;91:30-36.
DOI
|
| 15 |
Imagawa S, Yoshihara M, Ito M, et al. Evaluation of gastric cancer risk using topography of histological gastritis: a large-scaled cross-sectional study. Dig Dis Sci 2008;53:1818-1823.
DOI
|
| 16 |
Shichijo S, Hirata Y, Sakitani K, et al. Distribution of intestinal metaplasia as a predictor of gastric cancer development. J Gastroenterol Hepatol 2015;30:1260-1264.
DOI
|
| 17 |
Shiotani A, Iishi H, Uedo N, et al. Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer 2005;115:463-469.
DOI
|
| 18 |
Ohkusa T, Miwa H, Nomura T, et al. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients. Aliment Pharmacol Ther 2004;20 Suppl 1:25-32.
|
| 19 |
Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. J Gastroenterol Hepatol 2008;23:1666-1671.
DOI
|
| 20 |
Mizuno S, Miki I, Ishida T, et al. Prescreening of a highrisk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci 2010;55:3132-3137.
DOI
|
| 21 |
Asaka M, Mabe K, Matsushima R, Tsuda M. Helicobacter pylori eradication to eliminate gastric cancer: the Japanese Strategy. Gastroenterol Clin North Am 2015;44:639-648.
DOI
|
| 22 |
Reed C, Woosley JT, Dellon ES. Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis. Dig Liver Dis 2015;47:197-201.
DOI
|
| 23 |
Hayashi S, Imamura J, Kimura K, Saeki S, Hishima T. Endoscopic features of lymphoid follicles in Helicobacter pylori- associated chronic gastritis. Dig Endosc 2015;27:53-60.
DOI
|
| 24 |
Derakhshan MH, El-Omar E, Oien K, et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol 2006;59:1293-1299.
DOI
|
| 25 |
Massarrat S, Haj-Sheykholeslami A, Mohamadkhani A, et al. Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication. Biomed Res Int 2014;2014:481607.
|
| 26 |
Ito M, Haruma K, Kamada T, et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002;16:1449-1456.
DOI
|
| 27 |
Ahn SY, Lee SY, Hong SN, et al. Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and Cdx2 expression. Dig Dis Sci 2011;56:1119-1126.
DOI
|
| 28 |
Testoni PA, Bonassi U, Bagnolo F, Colombo E, Scelsi R. In diffuse atrophic gastritis, routine histology underestimates Helicobacter pylori infection. J Clin Gastroenterol 2002;35:234-239.
DOI
|
| 29 |
Korstanje A, van Eeden S, Offerhaus JA, et al. Comparison between serology and histology in the diagnosis of advanced gastric body atrophy: a study in a Dutch primary community. J Clin Gastroenterol 2008;42:18-22.
DOI
|
| 30 |
Kim DH, Kim GH, Kim JY, et al. Endoscopic grading of atrophic gastritis is inversely associated with gastroesophageal reflux and gastropharyngeal reflux. Korean J Intern Med 2007;22:231-236.
DOI
|
| 31 |
Lee JY, Kim N, Lee HS, et al. Correlations among endoscopic, histologic and serologic diagnoses for the assessment of atrophic gastritis. J Cancer Prev 2014;19:47-55.
DOI
|
| 32 |
Kokkola A, Sipponen P, Rautelin H, et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002;16:515-520.
DOI
|
| 33 |
Kang JM, Kim N, Shin CM, et al. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea. Helicobacter 2012;17:86-95.
DOI
|
| 34 |
Kawanaka M, Watari J, Kamiya N, et al. Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial. Br J Cancer 2016;114:21-29.
DOI
|
| 35 |
Yanaoka K, Oka M, Ohata H, et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 2009;125:2697-2703.
DOI
|
| 36 |
Shiotani A, Uedo N, Iishi H, et al. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion 2008;78:113-119.
DOI
|
| 37 |
Miki K, Fujishiro M, Kodashima S, Yahagi N. Longterm results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc 2009;21:78-81.
DOI
|
| 38 |
Venerito M, Malfertheiner P. Preneoplastic conditions in the stomach: always a point of no return? Dig Dis 2015;33:5-10.
DOI
|
| 39 |
Ghosh T, Lewis DI, Axon AT, Everett SM. Review article: methods of measuring gastric acid secretion. Aliment Pharmacol Ther 2011;33:768-781.
DOI
|
| 40 |
Chu S, Schubert ML. Gastric secretion. Curr Opin Gastroenterol 2012;28:587-593.
DOI
|
| 41 |
Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007;42:2-10.
DOI
|
| 42 |
Rehfeld JF, Bardram L, Hilsted L, Poitras P, Goetze JP. Pitfalls in diagnostic gastrin measurements. Clin Chem 2012;58:831-836.
DOI
|
| 43 |
Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015;64:1353-1367.
DOI
|
| 44 |
Choi IJ. Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer. Korean J Intern Med 2013;28:525-537.
DOI
|
| 45 |
Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006;9:245-253.
DOI
|
| 46 |
Park HK, Kim N, Lee SW, et al. The distribution of endoscopic gastritis in 25,536 heath check-up subjects in Korea. Korean J Helicobacter Up Gastrointest Res 2012;12:237-243.
DOI
|
| 47 |
Takao T, Ishikawa T, Ando T, et al. Multifaceted assessment of chronic gastritis: a study of correlations between serological, endoscopic, and histological diagnostics. Gastroenterol Res Pract 2011;2011:631461.
|
| 48 |
Yang JH, Lee SY, Hong SN, et al. Changing trends of serum pepsinogen I/II ratio in asymptomatic subjects. Korean J Helicobacter Up Gastrointest Res 2012;12:96-102.
DOI
|
| 49 |
Kono S, Gotoda T, Yoshida S, et al. Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan. World J Gastroenterol 2015;21:13113-13123.
DOI
|
| 50 |
Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007;56:631-636.
DOI
|
| 51 |
Song HJ, Jang SJ, Yun SC, et al. Low levels of pepsinogen I and pepsinogen I/II ratio are valuable serologic markers for predicting extensive gastric corpus atrophy in patients undergoing endoscopic mucosectomy. Gut Liver 2010;4:475-480.
DOI
|
| 52 |
Bang CS, Baik GH. Time to learn from the past and prepare for the future in Helicobacter pylori eradication. Korean J Intern Med 2015;30:789-791.
DOI
|
| 53 |
Graham DY. Roadmap for elimination of gastric cancer in Korea. Korean J Intern Med 2015;30:133-139.
DOI
|
| 54 |
Kim GH, Bang SJ, Ende AR, Hwang JH. Is screening and surveillance for early detection of gastric cancer needed in Korean Americans? Korean J Intern Med 2015;30:747-758.
DOI
|
| 55 |
Kokkola A, Kosunen TU, Puolakkainen P, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619-624.
DOI
|
| 56 |
Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, et al. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Cancer Epidemiol Biomarkers Prev 2008;17:2498-2504.
DOI
|
| 57 |
Kishikawa H, Nishida J, Ichikawa H, et al. Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status. Helicobacter 2011;16:427-433.
DOI
|
| 58 |
Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005;54:764-768.
DOI
|
| 59 |
Zhang X, Xue L, Xing L, et al. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community. Int J Cancer 2012;130:1614-1619.
DOI
|
| 60 |
Nomura S, Ida K, Terao S, et al. Endoscopic diagnosis of gastric mucosal atrophy: multicenter prospective study. Dig Endosc 2014;26:709-719.
DOI
|
| 61 |
Storskrubb T, Aro P, Ronkainen J, et al. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population. Scand J Gastroenterol 2005;40:302-311.
|
| 62 |
Kang HY, Kim N, Park YS, et al. Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig Dis Sci 2006;51:2310-2315.
DOI
|
webmaster
